Elabedin, H. Z. M., E. A. Hassan, M. A. E. Amir, M. E. M. Fatatry, H. M.Fahmy, and N. Zoheir,
"The Clinical Utility of Tissue Factor Level as a Biomarker in Multiple Myeloma",
Journal of American Science 2012;8(12, vol. 8, issue 12, 2012.
Hamdy, G., O. M. Hendy, H. M. Fahmy, A. El-sebaey, S. R. Ali, and F. A. Khalaf,
"Haptoglobin phenotypes as a risk factor for coronary artery disease in type 2diabetes mellitus: An Egyptian study",
The Egyptian Journal of Medical Human Genetics , vol. 15, pp. 257–264, 2014.
Sobhi, E., M. Elbasel, H. M. Fahmy, O. El-Serafi, and S. El-Shafee,
"Ischemic Strokes in HCV Patients with Bleeding Tendency,Is IT part of APL syndrome",
Kasr el-Aini Medical journal, vol. 14, issue 4, 2008.
Nabih, M., H. M. Fahmy, A. Abd-Elaziz, A. El-Hadidi, S. Mokhtar, and A. El-Shehabi,
"Osteoprottegerin and Soluble TRAIL serum level in patients with CAD.",
Journal of Egyptian Internal Medicine Society, vol. 18, issue 3, Submitted.
Nabih, M., H. M. Fahmy, A. Abd-Elaziz, A. El-Hadidi, S. Mokhtar, and A. El-Shehabi,
"Osteoprottegerin and Soluble TRAIL serum level in patients with CAD.",
Journal of Egyptian Internal Medicine Society, vol. 18, issue 3, Submitted.
Noha M El-Husseiny, H. Hady Goubran, H. M. Fahmy, N. M. Tawfik, H. Moustafa, S. N. Amin, and M. El-Ekiaby,
"Outcome and relapse risks of thrombotic thrombocytopaenic purpura: an Egyptian experience",
BMJ post graduate medical journal, vol. 88, issue 1042, pp. 433-436, 2012.
Wafaa H. El-Metnawy, M. M. Mattar, Y. H. El-Nahass, M. O. H. A. M. E. D. A. Samra, H. M. Abdelhamid, R. M. Abdlfattah, and A. R.,
"Predictive Value of Pretreatment BCR-ABLIS Transcript level on Response to Imatinib Therapy in Egyptian Patients with Chronic Phase CML",
International journal of Biomedical science March 2013 Vol. 9 No. 1, vol. 9, issue 1, pp. 48-53, 2013.